Related Experiment Video
Updated: May 27, 2026

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images
Published on: September 7, 2017
Preferential binding of the methyl-CpG binding domain protein 2 at methylated transcriptional start site regions
Amandine Chatagnon1, Laury Perriaud, Nicolas Nazaret
1Université de Lyon, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
Abstract:
Methyl-CpG Binding Domain (MBD) proteins are thought to be key molecules in the interpretation of DNA methylation signals leading to gene silencing through recruitment of chromatin remodeling complexes. In cancer, the MBD-family member, MBD2, may be primarily involved in the repression of genes exhibiting methylated CpG at their 5' end. Here we ask whether MBD2 randomly associates methylated sequences, producing chance effects on transcription, or exhibits a more specific recognition of some methylated regions. Using chromatin and DNA immunoprecipitation, we analyzed MBD2 and RNA polymerase II deposition and DNA methylation in HeLa cells on arrays representing 25,500 promoter regions. This first whole-genome mapping revealed the preferential localization of MBD2 near transcription start sites (TSSs), within the region analyzed, 7.5 kb upstream through 2.45 kb downstream of 5' transcription start sites. Probe by probe analysis correlated MBD2 deposition and DNA methylation. Motif analysis did not reveal specific sequence motifs; however, CCG and CGC sequences seem to be overrepresented. Nonrandom association (multiple correspondence analysis, p < 0.0001) between silent genes, DNA methylation and MBD2 binding was observed. The association between MBD2 binding and transcriptional repression weakened as the distance between binding site and TSS increased, suggesting that MBD2 represses transcriptional initiation. This hypothesis may represent a functional explanation for the preferential binding of MBD2 at methyl-CpG in TSS regions.
Insights
Methyl-CpG Binding Domain 2 (MBD2) preferentially binds methylated DNA near transcription start sites, suggesting a specific role in gene silencing. This nonrandom association links MBD2 to transcriptional repression, particularly at gene promoters.
Area of Science:
- Epigenetics
- Molecular Biology
- Genomics
Background:
- Methyl-CpG Binding Domain (MBD) proteins interpret DNA methylation for gene silencing.
- MBD2, an MBD family member, is implicated in cancer gene repression via promoter methylation.
Purpose of the Study:
- To investigate if MBD2 binding to methylated DNA is random or specific.
- To determine the relationship between MBD2 localization, DNA methylation, and gene transcription.
Main Methods:
- Whole-genome mapping using chromatin and DNA immunoprecipitation in HeLa cells.
- Analysis of MBD2 and RNA polymerase II occupancy on promoter regions.
- Correlation of MBD2 binding with DNA methylation status and gene expression.
Main Results:
- MBD2 preferentially localizes near transcription start sites (TSSs).
- MBD2 deposition strongly correlates with DNA methylation.
- A significant nonrandom association exists between MBD2 binding, DNA methylation, and gene silencing.
- MBD2 binding near TSSs is linked to transcriptional repression.
Conclusions:
- MBD2 exhibits specific recognition of methylated regions, not random association.
- MBD2 plays a direct role in repressing transcriptional initiation at methylated promoters.
- The findings provide a functional explanation for MBD2's preferential binding at methylated TSSs.
Related Concept Videos
Master Transcription Regulators
Cooperative Binding of Transcription Regulators
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
The Eukaryotic Promoter Region
RNA Polymerase II Accessory Proteins

